Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: EnteroMedics Inc

Market Cap 15.23M 13.31M 12.31M 11.49M 21.57M 1.44B 21.73M 146M 56.92M 708M 57.18M 55.94M 2.46B P/E 2026 *
-3.08x
P/E 2027 * -2.37x
Enterprise Value 15.23M 13.31M 12.31M 11.49M 21.57M 1.44B 21.73M 146M 56.92M 708M 57.18M 55.94M 2.46B EV / Sales 2026 *
102x
EV / Sales 2027 * 60.9x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -

Financials

2026 *2027 *
Net sales 150K 131K 121K 113K 212K 14.18M 214K 1.44M 561K 6.97M 563K 551K 24.21M 250K 218K 202K 189K 354K 23.63M 357K 2.4M 934K 11.62M 939K 918K 40.35M
Net income -4.89M -4.27M -3.95M -3.69M -6.93M -462M -6.98M -46.97M -18.27M -227M -18.36M -17.96M -789M -7.77M -6.79M -6.28M -5.86M -11M -734M -11.08M -74.62M -29.03M -361M -29.17M -28.54M -1.25B
Net Debt - -
Logo EnteroMedics Inc
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Employees
-
Sector
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!